Close
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting Jun 1, 2024 03:00PM

CHICAGO, June 1, 2024 /PRNewswire/ -- On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical research data for two of its products have been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The company will showcase the latest clinical trial findings for IMC001 in a poster presentation and for IMC002 in an online presentation during... (continue reading...)


First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process Jun 1, 2024 03:00PM

EVANSVILLE, Ind., June 01, 2024 (GLOBE NEWSWIRE) -- In recognition of National Homeownership Month, First Federal Savings Bank and the Independent Community Bankers of America (ICBA) are encouraging consumers to consult their local community banker about how to make the homebuying process simple, efficient and more affordable.

“Owning a home is a major purchase and an important component in building financial independence,” said Elisa Snyder FVP, Retail Lending... (continue reading...)


Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting Neuropathy Jun 1, 2024 02:40PM

LUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab counteracting the serious problem of chemotherapy induced neuropathy, an additional positive finding beyond its promising antitumor effects. The data focus on 73 pancreatic cancer patients receiving nadunolimab and chemotherapy. A key finding is higher dose levels of... (continue reading...)


Sun, Sand, and Smooth Skin: Grab Ulike Air 10 for a Summer Beach Adventure Jun 1, 2024 02:30PM

As the summer sun beckons and the waves call out, Ulike invites you to embark on the ultimate beach adventure. With its innovative hair removal solutions, including the Ulike Air 10, Ulike ensures you're ready to hit the sand with confidence and radiance.

London, England, United Kingdom - June 1, 2024 —

Key Features of the Ulike Air 10:

  • Powerful Dual Lights for Underarms: Inspired by salon laser technology, the Air 10's Dual Light technology ensures efficient and rapid... (continue reading...)

    • New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate) Jun 1, 2024 02:25PM
    • Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic (PK) profile based on the relevant PK modeling data
    • Additional data include new Phase 3 RISE and SHINE analyses demonstrating no new or unexpected safety concerns in young adults with schizophrenia treated with UZEDY
    • Global ADVANCE survey findings also reveal real-world experiences and perspectives on long-acting injectable... (continue reading...)

    More Press Releases

    View Older Stories

    Jun 1, 2024 02:20PM Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
    Jun 1, 2024 01:45PM Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd
    Jun 1, 2024 01:42PM Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
    Jun 1, 2024 01:20PM All-in-One Job Shop Software for Fabrication Shops by Steelhead Technologies
    Jun 1, 2024 12:43PM Sustainable Tourism Initiative: Responsible Travel Merchandise Store Announced
    Jun 1, 2024 02:20PM What Custom Stickers Are Best for Glass?
    Jun 1, 2024 02:20PM Robotbulls - The Future of Cryptocurrency Trading: Integrating AI and Blockchain Data
    Jun 1, 2024 01:10PM Taseko Announces that Operations at its Gibraltar Mine have been Suspended
    Jun 1, 2024 12:59PM Michael Bernstein Offers Dropshipping Consulting to Help Clients Build Successful, Long-Term Businesses
    Jun 1, 2024 01:02PM Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
    Jun 1, 2024 01:01PM PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
    Jun 1, 2024 12:55PM Union members and allies mark Injured Workers’ Day in locations across Ontario
    Jun 1, 2024 12:30PM FameEX CEO’s Message: Keep the Intention in the Crypto Bull Market for a Better Departure
    Jun 1, 2024 12:36PM Prospera Energy Inc. Announces 2023 Financial Results
    Jun 1, 2024 11:40AM Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
    Jun 1, 2024 11:00AM WATCH by Aisles: A Revolutionary AI System for Public Safety
    Jun 1, 2024 11:56AM CIO Women Magazine Spotlights Claudia Patricia Eusse, CEO, The Eusse Group, as Influential Women Leaders in Real Estate
    Jun 1, 2024 11:56AM Mr. Business Magazine Spotlights Diana Muniz-Lebrun, Founding Partner and CEO at Olympus Marketing
    Jun 1, 2024 11:00AM ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
    Jun 1, 2024 10:00AM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
    Jun 1, 2024 10:00AM Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
    Jun 1, 2024 10:00AM First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
    Jun 1, 2024 10:00AM "Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
    Jun 1, 2024 10:00AM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Jun 1, 2024 10:00AM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
    Jun 1, 2024 10:33AM Gregory P Lee Personal Injury Lawyer The Woodlands Expands Services to Meet Rising Demand in Texas for Personal Injury Cases
    Jun 1, 2024 10:30AM Innovative Solutions and Cutting-Edge Technologies Take Centre Stage at Water Expo Delhi 2024
    Jun 1, 2024 10:28AM Revolutionizing Sustainability: The Environment Protection Technologies Expo
    Jun 1, 2024 09:30AM Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
    Jun 1, 2024 09:15AM Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
    Jun 1, 2024 09:14AM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
    Jun 1, 2024 09:00AM Fungies Mushroom Gummies Announces Major Retail Expansion and Availability at Walmart
    Jun 1, 2024 09:00AM Vincent Todd Announces the Introduction of Todd Agriscience
    Jun 1, 2024 09:00AM Hyundai Motor America Reports May 2024 Sales
    Jun 1, 2024 09:00AM Beverly Hills MD Celebrates Its 10th Anniversary
    Jun 1, 2024 09:00AM American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information
    Jun 1, 2024 09:00AM Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
    Jun 1, 2024 09:00AM Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
    Jun 1, 2024 09:00AM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
    Jun 1, 2024 09:00AM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
    Jun 1, 2024 09:18AM 5 Ways BPO Services Can Improve Your Business Operations
    Jun 1, 2024 09:18AM Amazed by these incredible facts about the yellow diamond
    Jun 1, 2024 09:18AM Maximizing Efficiency: The Role of Content Moderation Services
    Jun 1, 2024 09:18AM Wisconsin Top Performing Stocks
    Jun 1, 2024 08:15AM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    Jun 1, 2024 08:15AM Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Jun 1, 2024 08:15AM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
    Jun 1, 2024 08:10AM Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
    Jun 1, 2024 08:05AM Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
    Jun 1, 2024 08:05AM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
    View Older Stories